Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Royal Bank Of Scotland Terug naar discussie overzicht

RBS week 43

1 Post
| Omlaag ↓
  1. forum rang 6 benbelegger 22 oktober 2013 08:25
    Gisteren een sterke daling , toekomst wisselvallig:

    uit The Guardian:

    Despite markets continuing to move higher in the wake of the recent US debt deal, Royal Bank of Scotland was under the cosh once more.

    Its shares fell 19.6p or 5% to 353.1p amid growing talk the government would split it into a good and bad bank, with many in the City believing this could be to the detriment of minority shareholders. On top of that, the banking sector came under pressure after JP Morgan reportedly made a tentative $13bn settlement relating to bad mortgage loans sold before the 2008 crisis. Others may have to follow suit. Nomura said:

    We think it is becoming more likely that the good bank/bad bank review will result in significant change for RBS. A decision is said to be imminent in the next few weeks and several options are being considered: 1) setting up a bad bank inside RBS to be run by an independent team; 2) setting up a bad bank inside RBS, in a model similar to that of UBS, which had more support from the central bank; 3) the final option would be the taxpayer-backed bad bank for the assets, similar to the solution from the Swedish government in the 1990s. We continue to believe that minority shareholders have much to lose from an unfavourable outcome of the review with the government maintaining considerable leverage over the minorities.

    On the US mortgage securities, Nomura said there was a material risk for RBS:

    RBS was involved in the sale of around $32bn of the MBS securities under scrutiny (similar to JP Morgan's $33bn). The largest Federal Housing Finance Agency (FHFA) suit is in Connecticut courts rather than New York, where more of the harsher settlements have been imposed and losses on RBS portfolios experienced by the FHFA have been said to be lower. However, due to the legal uncertainties and the large settlements discussed by the press, we see this as a material tail risk to the group. Potential capital release from [the sale of US subsidiary] Citizens helps in this context to plug any holes, though we don't see it as a means to buy back shares.
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.106
AB InBev 2 5.531
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.078
ABO-Group 1 23
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.829
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.804
Aedifica 3 925
Aegon 3.258 323.045
AFC Ajax 538 7.088
Affimed NV 2 6.305
ageas 5.844 109.901
Agfa-Gevaert 14 2.062
Ahold 3.538 74.349
Air France - KLM 1.025 35.265
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.049
Alfen 16 25.180
Allfunds Group 4 1.516
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 418
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.748
AMG 971 134.235
AMS 3 73
Amsterdam Commodities 305 6.744
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 495
Antonov 22.632 153.605
Aperam 92 15.047
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.798
Arcelor Mittal 2.034 320.943
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.350
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.597
ASML 1.766 109.813
ASR Nederland 21 4.507
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.834
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.447

Macro & Bedrijfsagenda

  1. 24 maart

    1. Samengestelde inkoopmanagersindex maart (Jap)
    2. Samengestelde inkoopmanagersindex maart (Fra)
    3. Samengestelde inkoopmanagersindex maart (Dld)
    4. Samengestelde inkoopmanagersindex maart (eur)
    5. Samengestelde inkoopmanagersindex maart (VK)
    6. Chicago Fed index februari (VS)
    7. Samengestelde inkoopmanagersindex maart (VS)
  2. 25 maart

    1. Ifo ondernemersvertrouwen maart (Dld)
    2. Case Shiller huizenprijzen januari (VS)
    3. Shell beleggersdag
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht